아시아태평양 유전자 합성 시장 규모 및 산업 예측

아시아 태평양 유전자 합성 시장

아시아 태평양 유전자 합성 시장 분석 및 통찰력

유전자 합성은 합성 생물학을 사용하여 실험실에서 인공 유전자를 만드는 과정입니다. 재조합 단백질의 생성은 유전자 합성이 핵심 도구로 부상하고 있는 재조합 DNA 기술의 수많은 응용 분야 중 하나입니다. 전통적인 클로닝 및 돌연변이 방법은 새로운 유전자 합성으로 빠르게 대체되고 있으며, 이를 통해 템플릿이 없는 핵산도 생산할 수 있습니다.

아시아 태평양 유전자 합성 시장

아시아 태평양 유전자 합성 시장은 2022년부터 2029년까지의 예측 기간 동안 성장할 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 24.7%의 CAGR로 성장하고 있으며 2021년의 4억 2,959만 달러에서 2029년까지 2,557,010,000달러에 도달할 것으로 분석했습니다.

보고서 메트릭	세부
예측 기간	2022년부터 2029년까지
기준 연도	2021
역사적 연도	2020 (2019-2014까지 사용자 정의 가능)
양적 단위	수익 (단위: USD 백만)
다루는 세그먼트	구성 요소별(합성기, 소모품, 소프트웨어 및 서비스), 유전자 유형(표준 유전자, 익스프레스 유전자, 복합 유전자 및 기타), 유전자 합성 유형(유전자 라이브러리 합성 및 사용자 정의 유전자 합성), 응용 프로그램(합성 생물학, 유전자 공학, 백신 설계, 치료 항체 및 기타), 방법(고체상 합성, 칩 기반 DNA 합성 및 PCR 기반 효소 합성), 최종 사용자(학술 및 연구 기관, 진단 연구소, 바이오텍 및 제약 회사 및 기타), 유통 채널(직접 입찰, 온라인 유통 및 제3자 유통업체)
적용 국가	중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 그리고 아시아 태평양의 나머지 지역입니다.
시장 참여자 포함	MACROGEN CO., LTD., Bioneer Pacific, Kaneka Eurogentec SA, Bbi-lifesciences, GCC Biotech (INDIA) Pvt. Ltd. 등이 있습니다.

시장 정의

Gene synthesis refers to the chemical synthesis of DNA strand base-by base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creating a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

Gene Synthesis Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers

INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES

Bacterial and viral diseases are rapidly expanding due to the rising prevalence of infectious diseases worldwide. As a result, the demand for novel and effective therapies has increased to fight against such deadly diseases. These diseases can be cured using chemical drugs and biological therapies, including gene therapy. By applying genomics, the management of infectious and endemic diseases has been enhanced. It also allows us to understand emerging drug resistance and identify targets for new therapeutics and vaccines. For the treatment of infectious diseases, gene therapy has attracted many researchers as it can be treated by using recombinant DNA technology, DNA &RNA ribozyme, and single chain antibodies.

As the rising prevalence of the chronic infectious disease is increasing globally, the demand for vaccines and effective gene therapy has also risen, which has increased the demand for novel genes with a significant application for research activities and drug and vaccine manufacturing. Thus, the rising prevalence of infectious diseases is acting as the driver for the gene synthesis market growth.

RISING ADOPTION OF GENE THERAPY

Gene therapy is an advanced technique that includes the usage of several genes for the prevention of a particular disease type. The technique involves the insertion of genes into patient cells instead of drugs and surgery. Due to increased demand for novel and long-lasting therapy results, the adoption of gene therapy is rising. Gene therapies demand synthetic gene constructs, among other gene products, to accelerate gene therapy development. Due to the rise in genetic diseases, the demand for a proper cure is one major factor, and with the help of gene therapy, a particular disease type can be cured.

Due to the increased demand, leaders are constantly focused on producing gene therapy products, achieving approval, and marketing authorizations.

Lifesaving medicines and therapies are in huge demand to provide quality life to different patients. These rising numbers of patients largely depend on the gene therapies available to achieve a proper cure. To manufacture gene therapies, synthetic and novel genes are required, which can be achieved by the gene synthesis technique. Thus, the rising adoption of gene therapy is expected to act as a driver for the gene synthesis market.

EXPANSION OF SYNTHETIC BIOLOGY

The incorporation of engineering principles into biology is termed synthetic biology. DNA genome can be reassembled with the help of synthetic biology as it involves the chemical synthesis of DNA by combining it with its genome. Oligonucleotides can be constructed in a short period by incorporating gene synthesis services, software, and consumables. As synthetic biology products' demand increases worldwide, gene synthesis products and services are also increasing.

Thus, due to its effective and innovative products, the demand for synthetic biology products is increasing globally, which is expected to act as a driving factor for the gene synthesis market.

Opportunities

RISING HEALTHCARE EXPENDITURE

Healthcare expenditure has increased worldwide as people's disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure.

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the medical device testing market in the forecast period of 2022-2029.

Restraints/Challenges

HIGH COST OF THE GENE SYNTHESIS PROCESS

However, the barriers to the gene synthesis techniques and the high cost of the gene synthesis process in some regions may impede the growth of the gene synthesis procedures hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be challenging factors for the growth of the market

This gene synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Recent Development

2020년 12월, Twist Bioscience는 유전자 제공을 완료하기 위해 클론 준비 유전자 단편을 출시했습니다. 출시된 단편은 어댑터와 함께 사용하거나 어댑터 없이 사용하여 완벽한 클론을 구축할 수 있습니다. 클론 준비 유전자 단편은 단백질 발현 경로, 효소 엔지니어링 및 유전자 발현 등과 호환됩니다.
ACS 저널에 게재된 기사에 따르면 2020년에 전 세계적으로 총 1,930만 건의 새로운 암 사례와 약 1,000만 건의 암 사망이 보고되었습니다. 이는 암 보장이 최적이 아니라는 것을 시사하며 전 세계적으로 높은 암 보장을 구현할 필요성이 매우 큽니다.

아시아 태평양 유전자 합성 시장 범위

아시아 태평양 유전자 합성 시장은 구성 요소, 유전자 유형, 유전자 합성 유형, 응용 프로그램, 방법, 최종 사용자 및 유통 채널로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내릴 수 있는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.

요소

신시사이저
소모품
소프트웨어 및 서비스

아시아 태평양 유전자 합성 시장은 구성 요소를 기준으로 합성기, 소모품, 소프트웨어 및 서비스로 구분됩니다.

유전자 유형

표준 유전자
유전자를 표현하다
복합 유전자
기타

유전자 유형을 기준으로 아시아 태평양 유전자 합성 시장은 표준 유전자, 표현 유전자, 복합 유전자 및 기타로 구분됩니다.

유전자 합성 유형

유전자 라이브러리 합성
맞춤형 유전자 합성

유전자 합성 유형을 기준으로 아시아 태평양 유전자 합성 시장은 유전자 라이브러리 합성과 맞춤형 유전자 합성으로 구분됩니다.

애플리케이션

합성생물학,
유전공학,
백신 설계,
치료제 항체
기타

아시아 태평양 유전자 합성 시장은 응용 분야를 기준으로 합성생물학, 유전공학, 백신 설계, 치료용 항체 등으로 구분됩니다.

방법

고체 기반 합성,
칩 기반 DNA 합성
PCR 기반 효소 합성

아시아 태평양 유전자 합성 시장은 이 방법을 기준으로 고체 기반 합성, 칩 기반 DNA 합성, PCR 기반 효소 합성으로 구분됩니다.

최종 사용자

학술 및 연구 기관,
진단 실험실,
바이오텍 & 제약 회사
기타

최종 사용자를 기준으로 아시아 태평양 유전자 합성 시장은 학술 및 연구 기관, 진단 실험실, 생명 공학 및 제약 회사 등으로 구분됩니다.

유통 채널

직접 입찰
온라인 배포
제3자 유통업체

유전자 합성 시장

아시아 태평양 유전자 합성 시장은 유통 채널을 기준으로 직접 입찰, 온라인 유통, 제3자 유통업체로 구분됩니다.

유전자 합성 시장 지역 분석/통찰력

유전자 합성 시장을 분석하고, 위에 언급된 대로 국가, 구성 요소, 유전자 유형, 유전자 합성 유형, 응용 분야, 방법, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

중국은 시장 점유율과 시장 수익 측면에서 아시아 태평양 유전자 합성 시장을 지배하고 있으며 예측 기간 동안 지배력을 계속 확대할 것입니다. 이는 이 지역에서 유전자 합성 프로세스의 검증 및 확인에 대한 필요성이 증가하고 있으며, 신속한 연구 개발이 시장을 촉진하고 있기 때문입니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 유전자 합성 시장 점유율 분석

유전자 합성 시장 경쟁 구도는 경쟁자에 의한 세부 정보를 제공합니다. 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우위가 포함됩니다. 위에 제공된 데이터 포인트는 유전자 합성 시장에 대한 회사의 초점에만 관련이 있습니다.

유전자 합성 시장의 주요 기업으로는 ATDBio Ltd(Biotage 자회사), General Biosystems, Inc., MACROGEN CO., LTD., Boster Biological Technology, Creative Biogene, Bioneer Pacific, exonbio, trenzyme GmbH, Twist Bioscience, BioCat GmbH(AddLife AB 자회사), OriGene Technologies, Inc., Integrated DNA Technologies, Inc.(9Danaher Corporation 자회사), Eurofins Scientific, NZYTech, Lda. - Genes and Enzymes, Ansa Biotechnologies, Inc., Thermo Fisher Scientific, Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG:biosynthetics GmbH, Merck KGaA, Kaneka Eurogentec SA, Ginkgo Bioworks, Bbi-lifesciences, Evonetix, ProMab Biotechnologies, Inc., GCC Biotech (INDIA) Pvt.가 있습니다. Ltd., CSBio, Azenta US, Inc. 등이 있습니다.

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 아시아 태평양 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가에게 전화를 요청하십시오.

SKU-62811

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Click on image to enlarge

대화형 데이터 분석 대시보드
높은 성장 잠재력 기회를 위한 회사 분석 대시보드
사용자 정의 및 질의를 위한 리서치 분석가 액세스
대화형 대시보드를 통한 경쟁자 분석
최신 뉴스, 업데이트 및 추세 분석
포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용

데모 요청

표 목록

TABLE 1 ASIA PACIFIC GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 2 ASIA PACIFIC SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 ASIA PACIFIC CONSUMABLES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 ASIA PACIFIC CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 ASIA PACIFIC SYNTHESIZER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 ASIA PACIFIC SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 ASIA PACIFIC GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 8 ASIA PACIFIC STANDARD GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 ASIA PACIFIC COMPLEX GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 ASIA PACIFIC EXPRESS GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 ASIA PACIFIC OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 ASIA PACIFIC GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 13 ASIA PACIFIC CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 ASIA PACIFIC CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 15 ASIA PACIFIC GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 ASIA PACIFIC GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 17 ASIA PACIFIC GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 18 ASIA PACIFIC SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 ASIA PACIFIC SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 20 ASIA PACIFIC GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 ASIA PACIFIC GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 22 ASIA PACIFIC THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 ASIA PACIFIC THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 24 ASIA PACIFIC VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 ASIA PACIFIC VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 26 ASIA PACIFIC OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 ASIA PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 28 ASIA PACIFIC PCR-BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 ASIA PACIFIC CHIP-BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 ASIA PACIFIC SOLID BASED SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 ASIA PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 32 ASIA PACIFIC ACADEMIC & RESEARCH INSTITUTES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 ASIA PACIFIC BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 ASIA PACIFIC OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 ASIA PACIFIC GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 37 ASIA PACIFIC DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 ASIA PACIFIC ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 41 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 42 ASIA-PACIFIC CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 43 ASIA-PACIFIC SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 45 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 46 ASIA-PACIFIC CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 47 ASIA-PACIFIC GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 48 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 49 ASIA-PACIFIC SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 50 ASIA-PACIFIC GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 51 ASIA-PACIFIC THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 52 ASIA-PACIFIC VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 53 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 54 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 55 ASIA-PACIFIC GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 56 CHINA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 57 CHINA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 CHINA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 CHINA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 60 CHINA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 61 CHINA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 62 CHINA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 63 CHINA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 CHINA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 65 CHINA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 66 CHINA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 67 CHINA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 68 CHINA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 69 CHINA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 70 CHINA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 71 JAPAN GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 72 JAPAN CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 73 JAPAN SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 JAPAN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 75 JAPAN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 76 JAPAN CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 77 JAPAN GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 78 JAPAN GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 79 JAPAN SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 80 JAPAN GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 81 JAPAN THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 82 JAPAN VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 83 JAPAN GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 84 JAPAN GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 85 JAPAN GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 86 INDIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 87 INDIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 NDIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 INDIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 90 INDIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 91 INDIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 92 INDIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 93 INDIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 94 INDIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 95 INDIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 96 INDIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 97 INDIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 98 INDIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 99 INDIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 100 INDIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 101 SOUTH KOREA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 102 SOUTH KOREA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 SOUTH KOREA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 SOUTH KOREA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 105 SOUTH KOREA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 106 SOUTH KOREA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 107 SOUTH KOREA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 108 SOUTH KOREA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 SOUTH KOREA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 110 SOUTH KOREA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 111 SOUTH KOREA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 112 SOUTH KOREA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 113 SOUTH KOREA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 114 SOUTH KOREA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 115 SOUTH KOREA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 116 AUSTRALIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 117 AUSTRALIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 118 AUSTRALIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 119 AUSTRALIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 120 AUSTRALIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 121 AUSTRALIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 122 AUSTRALIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 123 AUSTRALIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 124 AUSTRALIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 125 AUSTRALIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 126 AUSTRALIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 127 AUSTRALIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 128 AUSTRALIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 129 AUSTRALIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 130 AUSTRALIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 131 SINGAPORE GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 132 SINGAPORE CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 133 SINGAPORE SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 134 SINGAPORE GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 135 SINGAPORE GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 136 SINGAPORE CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 137 SINGAPORE GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 138 SINGAPORE GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 139 SINGAPORE SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 140 SINGAPORE GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 141 SINGAPORE THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 142 SINGAPORE VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 143 SINGAPORE GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 144 SINGAPORE GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 145 SINGAPORE GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 146 MALAYSIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 147 MALAYSIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 148 MALAYSIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 149 MALAYSIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 150 MALAYSIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 151 MALAYSIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 152 MALAYSIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 153 MALAYSIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 154 MALAYSIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 155 MALAYSIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 156 MALAYSIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 157 MALAYSIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 158 MALAYSIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 159 MALAYSIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 160 MALAYSIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 161 THAILAND GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 162 THAILAND CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 163 THAILAND SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 THAILAND GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 165 THAILAND GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 166 THAILAND CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 167 THAILAND GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 168 THAILAND GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 169 THAILAND SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 170 THAILAND GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 171 THAILAND THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 172 THAILAND VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 173 THAILAND GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 174 THAILAND GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 175 THAILAND GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 176 INDONESIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 177 INDONESIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 178 INDONESIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 179 INDONESIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 180 INDONESIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 181 INDONESIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 182 INDONESIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 183 INDONESIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 184 INDONESIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 185 INDONESIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 186 INDONESIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 187 INDONESIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 188 INDONESIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 189 INDONESIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 190 INDONESIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 191 PHILIPPINES GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 192 PHILIPPINES CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 193 PHILIPPINES SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 194 PHILIPPINES GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 195 PHILIPPINES GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 196 PHILIPPINES CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 197 PHILIPPINES GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 198 PHILIPPINES GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 199 PHILIPPINES SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 200 PHILIPPINES GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 201 PHILIPPINES THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 202 PHILIPPINES VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 203 PHILIPPINES GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 204 PHILIPPINES GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 205 PHILIPPINES GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 206 REST OF ASIA-PACIFIC GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

그림 목록

FIGURE 1 ASIA PACIFIC GENE SYNTHESIS MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC GENE SYNTHESIS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 ASIA PACIFIC GENE SYNTHESIS MARKET: DATA TRIANGULATION

FIGURE 4 ASIA PACIFIC GENE SYNTHESIS MARKET: SNAPSHOT

FIGURE 5 ASIA PACIFIC GENE SYNTHESIS MARKET: BOTTOM UP APPROACH

FIGURE 6 ASIA PACIFIC GENE SYNTHESIS MARKET: TOP DOWN APPROACH

FIGURE 7 ASIA PACIFIC GENE SYNTHESIS MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 ASIA PACIFIC GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA PACIFIC GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC GENE SYNTHESIS MARKET: END USER COVERAGE GRID

FIGURE 11 ASIA PACIFIC GENE SYNTHESIS MARKET: THE CATEGORY VS TIME GRID

FIGURE 12 ASIA PACIFIC GENE SYNTHESIS MARKET SEGMENTATION

FIGURE 13 GROWING PREVALENCE OF CHRONIC INFECTIOUS DISEASES , EXPANSION OF SYNTHETIC BIOLOGY AND RISING ADOPTION OF GENE THERAPY ARE EXPECTED TO DRIVE THE MARKET FOR ASIA PACIFIC GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 SYNTHESIZER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC GENE SYNTHESIS MARKET IN 2022 & 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC GENE SYNTHESIS MARKET

FIGURE 16 ASIA PACIFIC GENE SYNTHESIS MARKET: BY COMPONENT, 2021

FIGURE 17 ASIA PACIFIC GENE SYNTHESIS MARKET: BY COMPONENT, 2022-2029 (USD MILLION)

FIGURE 18 ASIA PACIFIC GENE SYNTHESIS MARKET: BY COMPONENT, CAGR (2022-2029)

FIGURE 19 ASIA PACIFIC GENE SYNTHESIS MARKET: BY COMPONENT, LIFELINE CURVE

FIGURE 20 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE TYPE, 2021

FIGURE 21 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE TYPE, 2022-2029 (USD MILLION)

FIGURE 22 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2022-2029)

FIGURE 23 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE

FIGURE 24 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2021

FIGURE 25 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2022-2029 (USD MILLION)

FIGURE 26 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, CAGR (2022-2029)

FIGURE 27 ASIA PACIFIC GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, LIFELINE CURVE

FIGURE 28 ASIA PACIFIC GENE SYNTHESIS MARKET: BY APPLICATION, 2021

FIGURE 29 ASIA PACIFIC GENE SYNTHESIS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 30 ASIA PACIFIC GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 31 ASIA PACIFIC GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 32 ASIA PACIFIC GENE SYNTHESIS MARKET: BY METHOD, 2021

FIGURE 33 ASIA PACIFIC GENE SYNTHESIS MARKET: BY METHOD, 2022-2029 (USD MILLION)

FIGURE 34 ASIA PACIFIC GENE SYNTHESIS MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 35 ASIA PACIFIC GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE

FIGURE 36 ASIA PACIFIC GENE SYNTHESIS MARKET: BY END USER, 2021

FIGURE 37 ASIA PACIFIC GENE SYNTHESIS MARKET: BY END USER, 2021-2029 (USD MILLION)

FIGURE 38 ASIA PACIFIC GENE SYNTHESIS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 39 ASIA PACIFIC GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 ASIA PACIFIC GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 41 ASIA PACIFIC GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 42 ASIA PACIFIC GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 43 ASIA PACIFIC GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 ASIA-PACIFIC GENE SYNTHESIS MARKET: SNAPSHOT (2021)

FIGURE 45 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COUNTRY (2021)

FIGURE 46 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 47 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 48 ASIA-PACIFIC GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029)

FIGURE 49 ASIA PACIFIC GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

What is the future market value for the Market?

The Asia-Pacific Gene Synthesis Market value is expected USD 2557.01 million by 2029.

What is the growth rate of the Market?

The Asia-Pacific Gene Synthesis Market is to grow at a CAGR of 24.7% during the forecast by 2029.

Who are the major players operating in the market?

The major players operating in the Asia-Pacific Gene Synthesis Market are MACROGEN CO., LTD., Bioneer Pacific, Kaneka Eurogentec S.A, Bbi-lifesciences, and GCC Biotech (INDIA) Pvt. Ltd., among others.

What are the significant factors flourishing the growth of the market?

The significant factors flourishing the growth of the Asia-Pacific Gene Synthesis Market are INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES, and RISING ADOPTION OF GENE THERAPY.

예측 기간	2022 –2029
시장 규모(기준 연도)	USD 429.59 Million
시장 규모(예측 연도)	USD 2,557.01 Million
연평균 성장률	24.70 %
주요 시장 플레이어	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 잠금 해제 요청

아시아 태평양 유전자 합성 시장 – 2029년까지의 산업 동향 및 예측

아시아 태평양 유전자 합성 시장 – 2029년까지의 산업 동향 및 예측

Asia Pacific Gene Synthesis Market

연평균 성장률 : 24.70 %

아시아 태평양 유전자 합성 시장 분석 및 통찰력

Gene Synthesis Market Dynamics

아시아 태평양 유전자 합성 시장 범위

유전자 합성 시장 지역 분석/통찰력

경쟁 환경 및 유전자 합성 시장 점유율 분석

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

목차

표 목록

그림 목록

연구 방법론

사용자 정의 가능

자주 묻는 질문

보고서

시장 통찰력

지원하다

솔루션

아시아 태평양 유전자 합성 시장 – 2029년까지의 산업 동향 및 예측

아시아 태평양 유전자 합성 시장 – 2029년까지의 산업 동향 및 예측

Asia Pacific Gene Synthesis Market

연평균 성장률 : 24.70 %

아시아 태평양 유전자 합성 시장 분석 및 통찰력

Gene Synthesis Market Dynamics

아시아 태평양 유전자 합성 시장 범위

유전자 합성 시장 지역 분석/통찰력

경쟁 환경 및 유전자 합성 시장 점유율 분석

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

목차

표 목록

그림 목록

연구 방법론

사용자 정의 가능

자주 묻는 질문

관련 페이지 탐색